SREBF1 and metabolic dysfunction-associated steatotic liver disease: As shown in Figs. 3 and 4, mRNA and protein expression levels of hepatic lipogenesis genes such as SREBP-1c, FAS, and ACC, were found to be increased in the NAFLD mice.